v3.26.1
Organization and Business Overview (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Jun. 30, 2025
Feb. 19, 2024
Dec. 31, 2025
Dec. 31, 2024
Oct. 24, 2025
Oct. 20, 2025
Jul. 02, 2025
Jun. 16, 2025
Preferred stock, par value     $ 0.001 $ 0.001       $ 0.001
Net cash outflows from operations     $ 13,361 $ 10,270        
Accumulated Deficit     127,945 117,409        
Cash and cash equivalents     6,392 $ 5,905        
Private Placement [Member]                
Private placement   $ 8,000 10,900          
Milestone payment     $ 1,000          
Investor [Member]                
Investment $ 11,000              
Investment $ 8,500              
Remaining investment         $ 2,500      
Series D Convertible Preferred Stock [Member]                
Preferred stock, par value             $ 0.001  
Biofrontera Group [Member] | Series D Convertible Preferred Stock [Member]                
Shares issued           3,019 3,019  
Preferred stock, par value           $ 0.001